期刊
JOURNAL OF HEPATOLOGY
卷 41, 期 1, 页码 31-37出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2004.03.008
关键词
autoimmunity; liver disease; regulatory T-cells
Background/Aims: CD4+ lymphocytes constitutively expressing the IL-2-receptor alpha-chain (CD25) regulate the activation of CD4 and CD8 autoreactive T-cells by suppressing their proliferation and effector function. The aim of this study is to: (1) measure the percentage of CD4+ CD25+ T-cells (T-regs) in patients with autoimmune liver disease at presentation and during remission, (2) correlate their frequency with disease activity, (3) determine their ability to expand and (4) to inhibit interferon-gamma (IFNgamma) production by CD4 + CD25- T-cells. Methods: 41 patients were studied. Percentage of T-regs was determined on peripheral blood mononuclear cells (PBMCs) by triple-colour flow cytometry; their ability to expand by exposing PBMCs to a T-cell expander (CD3/CD28 Dynabeads); their immunoregulatory function by measuring their ability to suppress IFNgamma production by CD4+ CD25- T-cells. Results: T-regs were significantly less in patients than in controls, and at diagnosis than during remission. Their percentage was inversely correlated with titres of anti-liver kidney microsomal and soluble liver antigen auto-antibodies. T-regs ability to expand was significantly lower in patients than in controls, but that to suppress IFNgamma production by CD4 + CD25- T-cells was maintained. Conclusions: Decreased T-regs numbers and ability to expand may favour the emergence of liver-targeted autoimmunity, despite preserved suppressor function. Treatment should aim at increasing T-regs number. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据